Literature DB >> 6544851

Voice rehabilitation after laryngectomy with the Groningen prosthesis.

J J Manni, P van den Broek, M A de Groot, E Berends.   

Abstract

The Groningen voice prosthesis is a recently developed silicone device for surgical rehabilitation of the voice following total laryngectomy. The prosthesis is placed in the tracheo-esophageal wall as a primary procedure during laryngectomy or as a secondary procedure some time after surgery. The insertion is a one stage surgical technique. The prosthesis is self-retaining and remains in situ, on average for three months. Its replacement is a simple outpatient procedure. Successful speech was achieved in 80% of the patients rehabilitated as a primary procedure. Aspiration of liquids or food was not observed. The Groningen prosthesis has several advantages over other currently available devices.

Entities:  

Mesh:

Year:  1984        PMID: 6544851

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  4 in total

Review 1.  Restoration of voice after laryngectomy.

Authors:  P Jassar; R J England; N D Stafford
Journal:  J R Soc Med       Date:  1999-06       Impact factor: 5.344

2.  Microbial colonization of tracheoesophageal voice prostheses (Provox2) following total laryngectomy.

Authors:  Brigita Tićac; Robert Tićac; Tomislav Rukavina; Palmira Gregorović Kesovija; Dijana Pedisić; Boris Maljevac; Radan Starcević
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-04-30       Impact factor: 2.503

3.  [A novel puncture instrument: the Provox-Vega® puncture set. Its use in voice prosthesis insertion following laryngectomy].

Authors:  K J Lorenz; F M Hilgers; H Maier
Journal:  HNO       Date:  2013-01       Impact factor: 1.284

4.  Development and (pre-) clinical assessment of a novel surgical tool for primary and secondary tracheoesophageal puncture with immediate voice prosthesis insertion, the Provox Vega Puncture Set.

Authors:  Frans J M Hilgers; Kai J Lorenz; Heinz Maier; Cees A Meeuwis; Jeroen D F Kerrebijn; Vincent Vander Poorten; Anne Sophie Vinck; Miquel Quer; Michiel W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-06       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.